neurological disorder

PF-CBP1 hydrochloride (PF-CBP1 HCl) is a highly selective inhibitor of the bromodomain of CREB-binding protein(CREBBP).It inhibits CREBBP and p300 bromodomains with IC50 of 125 and 363 nM respectively.

Bavisant (JNJ-31001074) is a selective and orally active Human H3 receptor antagonist. Bavisant can be used in research on mechanisms of action, involving wakefulness and cognition and the treatment for ADHD.

ESI-05 (NSC-116966) is a specific EPAC2 (exchange protein directly activated by cAMP 2) antagonist (IC50: 0.4 μM). ESI-05 inhibits cAMP-mediated activation of EPAC2, as well as EAPC2, mediated Rap1 activation.

GluR6 antagonist-1 inhibits the pY binding site of tyrosine kinase p56lck SH2 domain.

1. Ginkgetin has anti-influenza virus and anti-fungal activities. 2. Ginkgetin has anti-inflammatory activity, can down-regulates COX-2 induction in vivo against skin inflammatory responses. 3. Ginkgetin is a good STAT3 inhibitor and may be a useful lead

SLV-310 is a potent dopamine D2 receptor antagonist and 5-HT reuptake receptor inhibitor used in the study of neurological disorders such as bipolar disorder and schizophrenia.

Methylthiouracil is a thiourea-class antithyroid agent that inhibits the synthesis of thyroid hormones and is commonly used to treat hyperthyroidism. Studies have shown that Methylthiouracil can also suppress the production of TNF-α and IL-6, as well as inhibit the activation of NF-κB and ERK1/2. It can be used to induce hyperlipidemia and neurological disorder models.

4-Methoxyphenyl isothiocyanate (4-Methylphenyl ITC) is recognized as an antioxidant demonstrating an IC50 of 1.25 mM for scavenging DPPH free radicals. Its antioxidant capacity, as shown by the ORAC test, is 11.7 mM TE, equivalent to the efficacy of 11.7 mmol Trolox under similar conditions. Additionally, it extends the oxidation process in the Briggs–Rauscher reaction by approximately 9180 seconds. The compound also exhibits moderate cholinesterase inhibitory activity, with an inhibition rate of 30.4% for acetylcholinesterase (AChE) and 17.9% for butyrylcholinesterase (BChE). Research suggests 4-Methoxyphenyl isothiocyanate holds promise for applications in antioxidant and neurological disorder studies.

Fumiporexant (Compound Example 93) is an orally active, brain-penetrant, and selective antagonist of orexin receptor 2 (OX2R). It regulates the sleep-wake cycle and pathways related to mood in the central nervous system. Fumiporexant holds potential for research into neurological disorders such as insomnia and major depressive disorder.

5-Hydroxy-6-methoxy (S)-duloxetine maleate is an orally bioavailable and brain-penetrant serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor with antidepressant and analgesic properties. It holds potential for research in psychiatric and neurological disorders such as depression, diabetic neuropathic pain, generalized anxiety disorder, and fibromyalgia.

Nav1.7-IN-19 is a potent, selective, and orally active Nav1.7 inhibitor with an IC50 value of 0.49 μM. It shows high selectivity for Nav1.7, exhibiting 312-fold and 662-fold selectivity over Nav1.1 and Nav1.5, respectively, in the inactivated state. Nav1.7-IN-19 weakly inhibits the hERG potassium channel. Additionally, Nav1.7-IN-19 possesses analgesic properties, making it useful for neurological disorder research.

Rodin-C is a selective HDAC inhibitor, exhibiting IC50 values of 0.059 μM, 0.18 μM, and 5.39 μM for HDAC1, HDAC2, and HDAC11, respectively, with superior inhibitory effects compared to HDAC3-10. It significantly suppresses the HDAC-CoREST complex and demonstrates lower hematological toxicity. Rodin-C is applicable in neurological disorder studies, such as Alzheimer's disease research.

Carpipramine is an antipsychotic agent classified under the iminodibenzyl class. It acts as a potent dopamine antagonist and effectively blocks α1 and α2 adrenergic receptors. Additionally, carpipramine exhibits antagonistic effects on serotonin (5-HT2) receptors. This compound possesses both antischizophrenic and antidepressant properties, making it useful for research in neurological disorders such as post-traumatic stress disorder (PTSD) and depression.

3-Ethoxy-4-methoxy N,N-diethylhexedrone hydrochloride is an analog used in neurological disorder research.

α-Obscurine derivative-1 (Compound 7) is a derivative of α-Obscurine. It inhibits CaV3.1 ion channel currents with an IC50 of 0.19 μM and can be utilized in neurological disorder research.

Asenapine hydrochloride (Org 5222 hydrochloride) is a 5-hydroxytryptamine receptor, adrenergic receptor, dopamine receptor and histamine receptor antagonist with antipsychotic effects used in neurological disorders such as schizophrenia and bipolar disorder.

Trihydroxycholestanoic acid is an intermediate in the biosynthesis of cholic acid .1 Elevated plasma levels of trihydroxycholestanoic acid have been found in patients with Zellweger syndrome, a neurological disorder characterized by mutations in PEX genes which result in defects in peroxisome formation.2,3 |1. Keane, M.H., Overmars, H., Wikander, T.M., et al. Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice. Hepatology 45(4), 982-997 (2007).|2. Ferdinandusse, S., Overmars, H., Denis, S., et al. Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal α-methylacyl-CoA racemase deficiency. J. Lipid Res. 42(1), 137-141 (2001).|3. Klouwer, F.C.C., Berendse, K., Ferdinandusse, S., et al. Zellweger spectrum disorders: Clinical overview and management approach. Orphanet J. Rare Dis. 10, 151 (2015).

NMDA receptor modulator 2 (Compound 1) is a potent NMDA receptor modulator suitable for neurological disorder research [1].

NMDA receptor modulator 3 (Compound 99) is a potent NMDA receptor modulator useful in neurological disorder research [1].

NMDA receptor modulator 4 (Compound 169) is a potent NMDA receptor modulator used for neurological disorder research [1].

NMDA receptor modulator 5 (Compound 195), a potent NMDA receptor modulator, shows promise for neurological disorder research [1].

GW791343 trihydrochloride (GW791343 3HCl) is aHCl salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7.

FINDY, an inhibitor selective for the folding intermediate of DYRK1A, effectively blocks Ser97 autophosphorylation, exhibiting an IC50 of 35 μM. This compound is utilized in neurological disorder research.

α-Conotoxin Vc1.1 are potent, short peptide neurotoxins derived from the venom of marine cone snails that selectively and competitively block nicotinic acetylcholine receptors (nAChRs) in the nervous system, serving as highly specific molecular probes to dissect nAChR subtype function and as promising drug discovery leads for pain management, oncology research, and neurological disorder studies by precisely modulating neurotransmission, inhibiting nerve signal propagation, and inducing controlled paralysis in experimental systems.